24
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The Oxonate Pretreated Rat as A Model for Evaluating Hyperuricemic Effects of Antihypertensive Drugs

, &
Pages 487-504 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vilasinee Hirunpanich Sato, Bunleu Sungthong, Prasob-Orn Rinthong, Narawat Nuamnaichati, Supachoke Mangmool, Savita Chewchida & Hitoshi Sato. (2018) Pharmacological effects of Chatuphalatika in hyperuricemia of gout. Pharmaceutical Biology 56:1, pages 76-85.
Read now

Articles from other publishers (4)

Daniel Villalobos-García & Rolando Hernández-Muñoz. (2017) Catalase increases ethanol oxidation through the purine catabolism in rat liver. Biochemical Pharmacology 137, pages 107-112.
Crossref
Harumi Yamada, Hajime Kotaki, Hisao Furitsu, Yasufumi Sawada & Tatsuji Iga. (1999) Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: study using a rat model of hyperuricemia. Biopharmaceutics & Drug Disposition 20:2, pages 77-83.
Crossref
Takashi Dan, Takaaki Yoneya, Mitsu Onoma, Etsuro Onuma & Kazuharu Ozawa. (1994) Hypouricemic and uricosuric actions of AA-193 in a hyperuricemic rat model. Metabolism 43:1, pages 123-128.
Crossref
Yukio Yonetani, Mitsuo Ishii & Kazumi Iwaki. (1980) Hyperuricemia Induced by Some Antihypertensives and Uricosuric Drugs in Oxonate-Treated Rats. Japanese Journal of Pharmacology 30:6, pages 829-840.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.